Search

A new Canadian study shows that operating without interrupting warfarin treatment at the time of cardiac device surgery is safe and markedly reduces the incidence of clinically significant hematomas compared to the current standard of care.  The new findings were released today at Heart Rhythm 2013,the Heart Rhythm Society’s 34th Annual Scientific Sessions.

The Heart Rhythm Society (HRS), the European Heart Rhythm Association (EHRA) and Asia Pacific Heart Rhythm Society (APHRS), release the HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes. The expert consensus statement presented today at Heart Rhythm 2013, the Heart Rhythm Society’s 34th Annual Scientific Sessions, provides the first comprehensive statement of recommendations on the proper diagnosis and management of patients with inherited primary arrhythmia syndromes.

Hugh Calkins, MD, FHRS, CCDS, was named the president of the Heart Rhythm Society (HRS) during the 34th Annual Scientific Sessions, held in Denver last week.  Announced during the Presidents’ Reception on Friday, May 10th, Dr. Calkins now serves as the 35th president of HRS, making Anne M. Gillis, MD, FHRS, the immediate past president. Dr. Calkins is currently a Nicholas J. Fortuin Professor of Medicine and Professor of Cardiology at the Johns Hopkins University of Medicine in Baltimore, Maryland.

The National ICD Registry®, a repository of implantable cardioverter defibrillator (ICD) implantation data developed through a partnership of the Heart Rhythm Society (HRS) and the American College of Cardiology Foundation (ACCF), released the National ICD Registry Report: Version 2.1. The new version expands upon the 2009 Annual Report to now include data on leads and pediatric implants to reflect recent advancements in healthcare. This report is featured online in HeartRhythm, the official Journal of the Heart Rhythm Society.

As an Employer of Choice, The Heart Rhythm Society offers a robust benefit package., We are proud of our benefit offerings and believe they provide a substantial measure of security, protection and flexibility for our staff and their families, both now and in the future.

A new study shows young adults with congenital heart disease (CHD) also living with an implantable cardioverter- defibrillator (ICD) experience a high level of shock-related anxiety. The multicenter study, published in the June edition of HeartRhythm, the official journal of the Heart Rhythm Society, is the first to discover that shock-related anxiety is associated with sexual dysfunction in young adults and calls on healthcare providers to address these issues to improve the quality of life for patients.